Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Abroad (travel likely)RecruitingPHASE3

Conditions

Psoriatic Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • First OC Dermatology Research Inc., Fountain Valley, California, United States

    Contact: Study coordinator (Site Contact) · vivian.laquer@firstocdermresearch.com · 714-531-2966
    Contact: Principal Investigator (Vivian Laquer)
  • The Cohen Medical Centers, Thousand Oaks, California, United States

    Contact: Study coordinator (Site Contact) · drcohen@wmresearch.com · 805-904-0982
    Contact: Principal Investigator (Shariar Cohen-Gadol)
  • Denver Arthritis Clinic - Lowry, Denver, Colorado, United States

    Contact: Study coordinator (Site Contact) · rantolini@dacdenver.com
    Contact: Principal Investigator (Christopher Antolini)
  • Direct Helpers Research Center, Hialeah, Florida, United States

    Contact: Study coordinator (Site Contact) · don@dhrtrials.com · 305-828-3555
    Contact: Principal Investigator (Frank Don)
  • IRIS Research and Development, Plantation, Florida, United States

    Contact: Study coordinator (Site Contact) · drvalenzuela@irisrheumatology.com · 954-476-2338
    Contact: Principal Investigator (Guillermo Valenzuela)
  • Klein and Associates, M.D., P.A., Hagerstown, Maryland, United States

    Contact: Study coordinator (Site Contact) · ookoye@rheumdocs.com · 301-791-6680
    Contact: Principal Investigator (Okechukwu Okoye)
  • Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States

    Contact: Study coordinator (Site Contact) · idiabmd@gmail.com · 440-826-0742
    Contact: Principal Investigator (Isam Diab)
  • West Tennessee Research Institute, Jackson, Tennessee, United States

    Contact: Study coordinator (Site Contact) · aresearch@arthritisclinic.org · 731-633-0145
    Contact: Principal Investigator (Jacob Aelion)
  • Accurate Clinical Research, Baytown, Texas, United States

    Contact: Study coordinator (Site Contact) · snajammd@accurateclinicalresearch.com · 832-705-7839
    Contact: Principal Investigator (Sabeen Najam)
  • Novel Research LLC, Bellaire, Texas, United States

    Contact: Study coordinator (Site Contact) · wajeeha@novelresearch.net · 832-400-2262
    Contact: Principal Investigator (Wajeeha Yousaf)
  • Northwest Houston Arthritis Center, Houston, Texas, United States

    Contact: Study coordinator (Site Contact) · adnan@novelresearch.net · 832-834-5627
    Contact: Principal Investigator (Adnan Peer)
  • West Texas Clinical Research, Lubbock, Texas, United States

    Contact: Study coordinator (Site Contact) · jitendra.vasandani@yahoo.com · 806-993-1040
    Contact: Principal Investigator (Jitendra Vasandani)
  • Mie University Hospital, Tsu, Mie, Mie-ken, Japan

    Contact: Study coordinator (Site Contact) · yamake@clin.medic.mie-u.ac.jp · 81 (0) 59-231-5025
    Contact: Principal Investigator (Keiichi Yamanaka)
  • St. Luke's International Hospital, Chuo-ku, Tokyo, Japan

    Contact: Study coordinator (Site Contact) · satoshi.kawaai@gmail.com · +81 3-3541-5151
    Contact: Principal Investigator (Satoshi Kawaai)
  • National Hospital Organization Tokyo Medical Center, Meguro-Ku, Tokyo, Japan

    Contact: Study coordinator (Site Contact) · katsuyas.ntmc@gmail.com · 81 3-3411-0111
    Contact: Principal Investigator (Katsuya Suzuki)
  • Centro Reumatologico de Caguas, Caguas, Puerto Rico

    Contact: Study coordinator (Site Contact) · ajperez@crcsalud.com · 787-414-8465
    Contact: Principal Investigator (Amarilis Perez De Jesus)
Study leads
  • Study Director

    Takeda